SCYX
SCYNEXIS Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$0.822
Haut
$0.822
Bas
$0.822
Volume
0.15M
Fondamentaux de l'Entreprise
Statistiques de Trading
Actualités Connexes
SCYNEXIS Resumes Patient Dosing in Phase 3 MARIO Study
First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical holdResumption of dosing in this study triggers a $10M milestone payment from GSK plus an additional $20M milestone due in six
SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update
Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme.Hansoh recently
Actions Connexes
ICHR
Ichor Holdings Ordinary Shares
PFTA
Perception Capital Corp. III Ordinary Share
FUL
H. B. Fuller Company
TRVI
Trevi Therapeutics Inc.
FCNCO
First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.